No abstract available
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Atrophy / chemically induced
-
Atrophy / genetics
-
Atrophy / physiopathology
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Carboplatin / adverse effects
-
Carcinoma / drug therapy*
-
Carcinoma / secondary
-
Cerebellar Ataxia / chemically induced*
-
Cerebellar Ataxia / genetics*
-
Cerebellar Ataxia / physiopathology
-
Cerebellum / drug effects
-
Cerebellum / pathology
-
Cerebellum / physiopathology
-
Drug Resistance / genetics
-
Female
-
Fragile X Mental Retardation Protein / genetics
-
Fragile X Syndrome / genetics*
-
Genetic Predisposition to Disease / genetics
-
Heterozygote
-
Humans
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / secondary
-
Magnetic Resonance Imaging
Substances
-
FMR1 protein, human
-
Fragile X Mental Retardation Protein
-
Carboplatin